Skip to main content

Table 3 Incidence and risk ratio of adverse events between the two treatment groups

From: Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: a double-blind, parallel randomized clinical trial

Outcomes at 6-month follow-up

Treatment

RR

95 % CI

P value

Glucosamine plus diacerein

Glucosamine plus placebo

Diarrhea

0.84 (0.05–0.14)

0.81 (0.05–0.14)

1.03

0.56–1.89

0.932

Dyspepsia

0.03 (0.02–0.06)

0.03 (0.02–0.07)

0.91

0.43–1.92

0.805

  1. RR Risk ratio